These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6248185)

  • 21. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study.
    de Stavola BL; Gravelle IH; Wang DY; Allen DS; Bulbrook RD; Fentiman IS; Hayward JL; Chaudary MC
    Int J Epidemiol; 1990 Jun; 19(2):247-54. PubMed ID: 2376431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic parenchymal patterns and risk of breast cancer in postmenopausal women.
    Horwitz RI; Lamas AM; Peck D
    Am J Med; 1984 Oct; 77(4):621-4. PubMed ID: 6486138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population.
    Daye D; Keller B; Conant EF; Chen J; Schnall MD; Maidment AD; Kontos D
    Acad Radiol; 2013 May; 20(5):635-46. PubMed ID: 23570938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of breast cancer and changes in mammographic parenchymal patterns over time.
    Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
    Acta Oncol; 1998; 37(6):547-51. PubMed ID: 9860312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project.
    Brisson J; Morrison AS; Khalid N
    J Natl Cancer Inst; 1988 Dec; 80(19):1534-40. PubMed ID: 3255294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic error in breast disease.
    Meyer KK
    Am Surg; 1975 Dec; 41(12):774-85. PubMed ID: 173216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study.
    Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems.
    Nachtigall LE; Nachtigall RH; Nachtigall RD; Beckman EM
    Obstet Gynecol; 1979 Jul; 54(1):74-9. PubMed ID: 221871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
    Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
    Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammographic parenchymal patterns and risk factors for breast cancer.
    Ernster VL; Sacks ST; Peterson CA; Schweitzer RJ
    Radiology; 1980 Mar; 134(3):617-20. PubMed ID: 7355207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidences of breast cancer throughout long-term hormone replacement therapy.
    Cortés-Prieto J; Juez-Martel P
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):180-9. PubMed ID: 17467269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mammographic parenchymal patterns of women on hormonal replacement therapy.
    Kaufman Z; Garstin WI; Hayes R; Michell MJ; Baum M
    Clin Radiol; 1991 Jun; 43(6):389-92. PubMed ID: 2070578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast parenchymal patterns in women with bilateral primary breast cancer.
    Chaudary MA; Gravelle IH; Bulstrode JC; Wang DY; Bulbrook RD; Millis RR; Hayward JL
    Br J Radiol; 1983 Oct; 56(670):703-6. PubMed ID: 6616133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
    Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
    Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen therapy in carcinoma of the breast (author's transl)].
    Völker W; Kannengiesser U; Majewski A
    Geburtshilfe Frauenheilkd; 1980 Feb; 40(2):125-32. PubMed ID: 6245009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.